About: Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.49 (-1.32%)
CTXR NASDAQ Citius Pharmaceuticals Inc
Citius Pharmaceuticals Inc share price
CTXR price activity
Last Price
$0.490
Change (24hr)
-0.01 USD (-1.32%)
Volume
115.60K
Volume (4w avg)
-
Open
$0.49
Day Range
$0.49 - $0.49
Previous Close
$0.50
Last Trade
12 Oct, 8:00 pm GMT+0
Delayed
12 Oct, 8:00 pm GMT+0
CTXR price performance
Delayed
12 Oct, 8:00 pm GMT+0
CTXR Market Signals